OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Destination Vector pLenti-EF1a-C-Myc-DDK-IRES-Puro     

Lenti Vector with EF1 alpha promoter and bicistronic IRES-Puro, 10ug       

Specifications Custom Cloning Product Manual FAQs
Catalog No. Description Price Availability  
PS100085 Lenti Vector with EF1 alpha promoter and bicistronic IRES-Puro, 10ug        $670 In Stock
Add to Shopping Cart
Features:

This Lenti vector is a third generation of lentiviral vector.

  • All OriGene’s TrueORF clone can be shuttled into this vector via PrecisionShuttling, a simple cut-and-ligation process.
  • The expression of the cloned ORF is driven by EF1a, a constitutive promoter as an alternative of CMV promoter. The latter could be silenced in certain cellular environment.
  • The ORF cloned in this vector can be expressed as a tagged protein with c-terminal Myc-DDK tags.
  • IRES-Puro is within the Lentiviral packaging cassette and would allow Puromycin selection in both the transfected and the transduced cells.
  • A brief lentiviral packaging protocol is provided
  • E. Coli selection: Chloramphenicol(34ug/ml)
Lenti Vector with EF1 alpha promoter and bicistronic IRES-Puro, 10ug         Vector Image
Schematic of the multiple cloning sites:
Lenti Vector with EF1 alpha promoter and bicistronic IRES-Puro, 10ug         MCS Image
Download full vector sequence

 

pattern
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title